STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 52 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,552,000 | +2.2% | 914,062 | -0.4% | 0.45% | +1.1% |
| Q3 2018 | $4,453,000 | -61.3% | 918,132 | -52.1% | 0.45% | -69.7% |
| Q2 2018 | $11,509,000 | -32.2% | 1,918,132 | 0.0% | 1.48% | -38.3% |
| Q1 2018 | $16,975,000 | -4.5% | 1,918,132 | -21.8% | 2.40% | -36.8% |
| Q4 2017 | $17,780,000 | -13.0% | 2,452,397 | -17.2% | 3.81% | -7.8% |
| Q3 2017 | $20,442,000 | -4.7% | 2,962,645 | -1.2% | 4.13% | -23.5% |
| Q2 2017 | $21,450,000 | +50.5% | 3,000,000 | 0.0% | 5.40% | +28.9% |
| Q1 2017 | $14,250,000 | +97.9% | 3,000,000 | 0.0% | 4.19% | +76.7% |
| Q4 2016 | $7,200,000 | – | 3,000,000 | – | 2.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,394,994 | $12,948,000 | 44.18% |
| Vivo Capital, LLC | 3,000,000 | $7,200,000 | 2.37% |
| Opaleye Management Inc. | 1,160,000 | $2,784,000 | 1.64% |
| Granite Point Capital Management, L.P. | 606,607 | $1,456,000 | 1.16% |
| Boxer Capital, LLC | 940,000 | $2,256,000 | 0.87% |
| RA Capital Management | 2,279,099 | $5,470,000 | 0.78% |
| Broadfin Capital, LLC | 2,894,581 | $6,947,000 | 0.77% |
| NEA Management Company, LLC | 4,141,308 | $9,939,000 | 0.40% |
| Tredje AP-fonden | 909,581 | $2,183,000 | 0.09% |
| Anson Funds Management LP | 92,219 | $221,000 | 0.07% |